| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 药品经营(元) | 33,668,652,979.28 | 66,147,208,864.58 | 33,030,887,208.66 |
| 医疗器械类(元) | 6,883,640,002.86 | 12,748,262,864.86 | 5,944,351,150.91 |
| 其他(元) | 635,924,349.70 | 1,666,060,017.94 | 803,989,343.36 |
| 营业成本(元) | |||
| 药品经营(元) | 31,330,390,709.59 | 61,816,442,212.79 | 30,732,799,578.67 |
| 医疗器械类(元) | 6,218,981,130.16 | 11,312,750,581.30 | 5,161,023,405.70 |
| 其他(元) | 628,473,648.98 | 1,443,765,486.99 | 794,801,049.99 |
| 毛利(元) | |||
| 药品经营(元) | 2,338,262,269.69 | 4,330,766,651.79 | 2,298,087,629.99 |
| 医疗器械类(元) | 664,658,872.70 | 1,435,512,283.56 | 783,327,745.21 |
| 其他(元) | 7,450,700.72 | 222,294,530.95 | 9,188,293.37 |
| 毛利率(%) | |||
| 药品经营(%) | 6.94 | 6.55 | 6.96 |
| 医疗器械类(%) | 9.66 | 11.26 | 13.18 |
| 其他(%) | 1.17 | 13.34 | 1.14 |
| 收入构成(%) | |||
| 药品经营(%) | 81.74 | 82.11 | 83.04 |
| 医疗器械类(%) | 16.71 | 15.82 | 14.94 |
| 其他(%) | 1.54 | 2.07 | 2.02 |
| 毛利构成(%) | |||
| 药品经营(%) | 77.67 | 72.32 | 74.36 |
| 医疗器械类(%) | 22.08 | 23.97 | 25.35 |
| 其他(%) | 0.25 | 3.71 | 0.30 |